Warren A. Kaplan, PhD, JD, MPH

Clinical Assistant Professor, Global Health
Warren Kaplan
(617) 414-1152wak@bu.edu
Crosstown Center – CT395
View full profile at BUMC

Biography

Intellectual property, trade and public health Access to medicines and devices Pharmaceutical policy Prevention and treatment of diabetes Pharmaceutical pricing and market dynamics

Education

  • Suffolk University, JD
  • Boston University, PhD
  • Boston University School of Public Health, MPH
  • Texas A & M University, MS
  • City University of New York-Queens College, BA

Classes Taught

  • SPHGH885
  • SPHGH891

Publications

  • Published on 7/19/2016

    Kaplan WA, Beall RF. The global intellectual property ecosystem for insulin and its public health implications: an observational study. J Pharm Policy Pract. 2017; 10:3. PMID: 27446593.

    Read at: PubMed
  • Published on 6/1/2016

    Mishra SR, Sharma A, Kaplan WA, Adhikari B, Neupane D. Liberating data to combat NCDs. Lancet Diabetes Endocrinol. 2016 Jun; 4(6):482-3. PMID: 27207276.

    Read at: PubMed
  • Published on 5/24/2016

    Wirtz VJ, Kaplan WA, Kwan GF, Laing RO. Access to Medications for Cardiovascular Diseases in Low- and Middle-Income Countries. Circulation. 2016 May 24; 133(21):2076-85. PMID: 27217433.

    Read at: PubMed
  • Published on 5/18/2016

    Mishra SR, Sharma A, Kaplan WA, Adhikari B, Neupane D. (2016). Lancet Diabetes & Endocrinology. 2016.

    Read at: Custom
  • Published on 3/14/2016

    Sharma A, Kaplan WA, Chokshi M, Zodpey SP. Role of the private sector in vaccination service delivery in India: evidence from private-sector vaccine sales data, 2009-12. Health Policy Plan. 2016 Sep; 31(7):884-96. PMID: 26976803.

    Read at: PubMed
  • Published on 2/24/2016

    Beall RF, Nickerson JW, Kaplan WA, Attaran A. Is Patent "Evergreening" Restricting Access to Medicine/Device Combination Products? PLoS One. 2016; 11(2):e0148939. PMID: 26910128.

    Read at: PubMed
  • Published on 2/1/2016

    Kaplan W, Laing R, Ewen M, Beran D. Insulin patents and market exclusivities: unresolved issues. Lancet Diabetes Endocrinol. 2016 Feb; 4(2):98. PMID: 26825233.

    Read at: PubMed
  • Published on 2/23/2015

    Sharma A, Kaplan WA, Chokshi M, Hasan Farooqui H, Zodpey SP. Implications of private sector Hib vaccine coverage for the introduction of public sector Hib-containing pentavalent vaccine in India: evidence from retrospective time series data. BMJ Open. 2015; 5(2):e007038. PMID: 25712822.

    Read at: PubMed
  • Published on 3/13/2014

    Kaplan WA, Wirtz VJ. A research agenda to promote affordable and quality assured medicines. J Pharm Policy Pract. 2014; 7:2. PMID: 25848542.

    Read at: PubMed
  • Published on 9/30/2013

    Kaplan WA, Wirtz VJ, Stephens P. The market dynamics of generic medicines in the private sector of 19 low and middle income countries between 2001 and 2011: a descriptive time series analysis. PLoS One. 2013; 8(9):e74399. PMID: 24098644.

    Read at: PubMed

View 12 more publications:View full profile at BUMC

News & In the Media